Michael holds a degree in biology from the University of Konstanz, Germany. He started his scientific career participating in several research projects at the Oregon State University and the Florida Atlantic University. In 2006, he returned to Europe and continued his work as a research scientist at the Centre for Genomic Regulation in Barcelona.
He began his career as a regulatory affairs consultant when he joined ASPHALION, S.L. in 2007. Nowadays, his responsibilities include the strategy and management of international drug registration procedures, the preparation and evaluation of the respective dossiers, as well as the conduct of scientific advice procedures and pre-submission meetings with international regulatory authorities. He acquired specific knowledge in several projects for innovative products, such as Biologicals and Advanced Therapy Medicinal Products. Other areas of his expertise include the strategic preparation of paediatric investigation plans as well as the implementation of electronic submission standards.
In 2013, Michael moved to Munich, thus returning to his home country Germany, where he established ASPHALION’s first branch office.